中概股深夜拉升，美股减肥药巨头狂泻14%，黄金重回5200美元，国际油价走强

Market Overview - US stock markets opened lower due to uncertainty in trade policies, with the Nasdaq down 0.23%, Dow Jones down 0.05%, and S&P 500 down 0.02% [1] - Major tech stocks experienced declines, with Tesla dropping over 2%, Amazon and Microsoft nearly 2%, and Facebook close to 1% [2] Company Performance - Novo Nordisk's stock fell nearly 14% after its next-generation weight loss drug CagriSema showed a weight loss effect of 20.2% over 84 weeks, compared to Eli Lilly's Tirzepatide, which achieved 23.6% [2][3] - Chinese concept stocks mostly rose, with Atour, NIO, and Hesai Technology increasing over 3%, while Li Auto and Weibo rose over 2% [4] Commodity Market - Gold prices surged, with spot gold nearing $5,200 per ounce, and NYMEX gold rising 2.67% to surpass this threshold [5] - Silver also saw significant gains, with spot silver increasing over 3% [6] - Both Brent and WTI crude oil prices rose by over 0.6% [7] Economic Indicators - The US January CPI rose 2.4% year-on-year, below the expected 2.5%, and core CPI increased by 2.5%, aligning with expectations [8] - The Federal Reserve's January meeting minutes revealed significant internal divisions among committee members regarding inflation persistence [8] - Recent changes in US trade policy include a Supreme Court ruling against large-scale tariffs, followed by an announcement of a 10% import tariff on global goods, which was later increased to 15% [8][9]